Euda Health Holdings Ltd (EUDA) Stock Price & Analysis
Euda Health Holdings Ltd (EUDA) rose 2.74% to USD 14.99 as of July 25, 2026 at 22:23 UTC, according to Nexqual real-time market data.
EUDA last closed at USD 14.59; the session ranged USD 14.9–15.1 on volume of 9,868 shares. Market capitalization is $44.88M, with a 52-week range of USD 5.26–86 (NCM). Source: Nexqual, July 25, 2026 at 22:23 UTC.
Key Statistics (as of July 25, 2026 at 22:23 UTC)
| Price | USD 14.99 |
|---|---|
| Change | ▲ 2.74% (up) |
| Previous Close | USD 14.59 |
| Open | USD 14.95 |
| Day Range | USD 14.9 – 15.1 |
| 52-Week Range | USD 5.26 – 86 |
| Volume | 9,868 shares |
| Market Cap | $44.88M |
| Exchange | NCM |
Technical Analysis (EUDA)
Nexqual's technical model rates EUDA "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 22:23 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 55.1 (neutral) |
| vs SMA50 | Above (USD 14.88) |
| MACD | -0.13 (negative) |
Analyst Ratings (EUDA)
Wall Street analysts rate EUDA "None" based on 1 analysts, with a mean price target of USD 55 (range USD 55–55), per Nexqual as of July 25, 2026 at 22:23 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 55 |
| High Target | USD 55 |
| Low Target | USD 55 |
Earnings (EUDA)
Source: Nexqual, July 25, 2026 at 22:23 UTC.
Financials & Fundamentals (EUDA)
| Total Revenue | $6.82M |
|---|---|
| Revenue Growth (YoY) | +78.90% |
| Gross Margin | +43.88% |
| Operating Margin | -34.77% |
| Profit Margin | -40.66% |
| Current Ratio | 0.18 |
| Total Cash | $345,145 |
| Total Debt | $2.40M |
| Free Cash Flow | $-953,881 |
Source: Nexqual, July 25, 2026 at 22:23 UTC.
Financial Health Score (EUDA)
Nexqual rates Euda Health Holdings Ltd's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 22:23 UTC.
| Growth | Strong — Revenue +70% YoY (annual) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $345K cash vs $2M debt |
| Cash Flow | Weak — FCF negative: -$954K, burning cash |
| Efficiency | Mixed — No data |
Ownership (EUDA)
| Insider Ownership | +49.42% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.99M |
| Float | 1.11M |
| Short % of Float | +0.25% |
Source: Nexqual, July 25, 2026 at 22:23 UTC.
Leadership (EUDA)
Euda Health Holdings Ltd is led by Alfred Lim (age 73), CEO & Executive Director, per Nexqual as of July 25, 2026 at 22:23 UTC.
| CEO & Executive Director | Alfred Lim (age 73) |
|---|---|
| Chief Technology Officer | Daniel Tan (age 43) |
| Interim Chief Financial Officer | Whye Shin Tay (age 39) |
| Operational Director | Aaron Lim |
| Managing Director of EUDA Health Malaysia Sdn Bhd | Johnson Tang |
From Euda Health Holdings Ltd's Latest SEC 10-K Filing (filed 2023-06-28)
Key Strengths & Strategy (as disclosed to the SEC)
- EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China.
- It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services.
- The company also provides property management services.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GSUN | Golden Sun Technology Group Lim | USD 0.21 | ▼ 23.72% |
| MVLA | Movella Holdings Inc. | USD 0 | ▲ 0% |
| HTCR | Heartcore Enterprises, Inc. | USD 2.18 | ▼ 11.54% |
| JCSE | JE Cleantech Holdings Limited | USD 1.36 | ▼ 2.86% |
| CMRA | Comera Life Sciences Holdings, | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 22:23 UTC. This page is informational and not investment advice.